Back

Maternal transfer of IgA and IgG SARS-CoV-2 specific antibodies transplacentally and via breastfeeding

Sajadi, M. M.; Shokatpour, N.; Bathula, A.; Tehrani, Z.; Lankford, A.; Purcell, M.; Campbell, J. D.; Hammershaimb, E. A. D.; Deatrick, K. B.; Bor, C.; Parsell, D. M.; Dugan, C.; Levine, A.; Ramelli, S. C.; Chertow, D.; Herr, D. L.; Lewis, G. K.; Grazioli, A.

2021-12-23 infectious diseases
10.1101/2021.12.21.21267733 medRxiv
Show abstract

Although there have been many studies on antibody responses to SARS-CoV-2 in breastmilk, very few have looked at the fate of these in the baby. We carried out a study in 22 mother/baby pairs (mothers who breastfed and who were SARS-CoV-2 vaccinated before or after delivery) looking at mother blood, mother milk, baby blood, baby nose, and baby stool. Breastfed infants only acquired systemic anti-SARS-CoV-2 IgG antibodies if their mothers were vaccinated antepartum. None of the infants had SARS-CoV-2-specific IgA in the blood, but surprisingly, half of the infants in the Antepartum group had high titer SARS-CoV-2-specific IgA in the nose that exceeded titers found in breastmilk. Vaccination antepartum followed by breastfeeding appears to be the best way to provide systemic and local anti-SARS-CoV-2 antibodies for infants.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.